The Asian Pacific Association for the Study of the Liver [APASL]

Monthly News

Message from the Organizer of APASL STC 2016 in Turkey

APASL STC İstanbul has been postponed

Dear Colleagues,

Taking into account the general tendency of the members of the Steering Committee and the current state of Turkey, the APASL STC İstanbul has been postponed to a later date which will be confirmed in 2017 by the Steering Committee. We would like to thank you for your supports and would like to see you among us at the congress on the new designated date.

Kind regards,

  • Prof. A. Kadir DOKMECİ, MD
    Honorary President
  • Prof. Necati ORMECİ, MD
    Congress President
  • Prof. Hasan OZKAN, MD
    Congress Secretary General

APASL STC on Non-Responders in Turkey

Date: Postponed
City: Istanbul, Turkey
President: Dr. Necati Ormeci
Website: http://www.apaslstcturkey2016.com/


APASL2017 in Shanghai


Dear Colleagues,

We are delighted and honored to introduce you to the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), which will take place at Shanghai International Convention Center, on 16-19 February 2017 in Shanghai, China. We will bring together a distinguished faculty of renowned specialists from Asia Pacific and around the world to this conference.

APASL annual meeting has grown as the leading conference focusing on remarkable progress in liver disease, aimed to provide the latest scientific and evidence-based research result that will be applicable to the everyday clinical practice. It provides an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries. These elements are essential to pave a way for better development of Hepatology.

We planned to have a three-day core program to provide an overview of varies liver diseases with the State-of- the Art Lectures on hot-off-the-press issues. Besides, Postgraduate Courses and Morning Sessions will be de- signed for the in-depth discussion on particular topics.

Free paper and poster presentation is always the soul of the conference to share research findings and there will be several awards available for application aimed to support young scientists to attend the conference and encourage scientific research.

We thus enthusiastically invite you to submit abstract and join us in this conference as well as our blooming city – Shanghai.

We look forward to welcoming you in Shanghai!


Prof. Jinlin Hou

President of APASL2017



APASL STC 2016 in Kaohsiung Report




APASL STC 2016 in Beijing


Dear, Colleagues and Distinguished Guests,

On behalf of the Organizing Committee and Scientific Committee, it is our great pleasure to welcome you to join the APASL STC 2016 – 6thHBV Conference, which will be held on December 16-18, 2016 in Beijing, China.

As an influential and responsible academic association, APASL always promotes research and education in hepatology and focuses on combating liver diseases. The APASL Single Topic Conference (STC) is dedicated to the advancement of liver diseases treatment in Asian-Pacific countries and provide an excellent communication platform for global and regional hepatologists. The theme of this conference is “Enhancing Knowledge for Better Patient Care”. Currently, chronic HBV infection remains a serious public health problem due to its worldwide distribution and potential severe outcomes, particularly in the Asian-Pacific region. In the last two decades, with the effort of researchers and clinicians, great progresses in this field have been made. The most up-to-date findings from the translational medicine to the clinical management of viral hepatitis B infection, including prevention and control, novel targets and drug discovery, biomarkers and diagnosis, and the treatment guidelines will be discussed. The experts will bring their didactic lectures to join together and make this conference an unforgettable academic event.

For APASL, China is a major center for basic and clinical research of liver diseases. We are therefore delighted to host 2016 APASL STC in Beijing., the capital of China and an international hub that connecting China and the world. We believe that extensive discussions and wonderful experience will be shared between Chinese doctors and international colleagues.

Prof. Lai Wei

Congress Chairman APASL STC-6th HBV Conference


APASL STC on HBV in China

Date: December 16-18, 2016
City: Beijing, China
President: Dr. Lai Wei
Website:http://www.apaslbeijing.org/


APASL STC 2017 in Nagasaki


Dear Colleagues,

On behalf of the Organizing Committee, it gives us great pleasure to invite you to the 23rd Asian Pacific Association for the Study of the Liver Single Topic Conference (APASL STC), which will be held on April 10-12, 2017 in Nagasaki, Japan. We are delighted to welcome you to the beautiful, exotic city of Nagasaki in Kyushu Island of Japan.

Under the theme of “Prevention of HCC Development,” the conference program will present high-quality content based on up-to-date information and cutting edge lectures by eminent researchers, in order to reconfirm the achievement of better basic and clinical practice in the field of Prevention of HCC Development.

The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers on significant developments on the theme of Prevention and Management of HCC Development. The program will also provide the latest information and fresh ideas for hepatologists.

The conference will encourages the submission of abstracts on research for oral and poster presentations through the conference website. We would appreciate your submission and anticipate a large number of entries, which will stimulate active discussions.

Approximately 1000 delegates of experts from all over the world are expected to attend this conference. We are sure that this will provide an excellent opportunity for those of us in the Asian Pacific region to share the latest views, values, experience and practice, and greatly contribute to the progress of Prevention of HCC Development.

We are looking forward to welcoming you to Nagasaki in the season when tulips, daffodils and other flowers are in full bloom in a popular park situated just across the street from the conference venue.

With warmest regards,

Hiroshi Yatsuhashi M.D.

President, The 23rd APASL Single Topic Conference in Nagasaki

Director General, Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center

Professor, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences


APASL STC on Prevention of HCC development in Japan

Date: April 10-12, 2017
City: Nagasaki, Japan
President: Dr. Hiroshi Yatsuhashi
Website: http://www.apaslstc2017nagasaki.org/


APASL STC 2017 in Cairo


Dear Colleagues,

We are delighted and honored to introduce you to the Single topic Conference on HCV (Real Life Experience) of the Asian Pacific Association for the Study of the Liver (APASL) which will be held at Intercontinental City Stars hotel Convention Center, on 6-8 September 2017 in Cairo, Egypt. We will bring together a distinguished faculty of renowned specialists from AsiaPacific and around the world to this conference.

After the two successful liver fibrosis STC meetings in Cairo on 2008 and 2014, the coming congress have been selected to focus on HCV and its remarkable fast progress in the new treatment modalities. Egyptians have the highest world prevalence of HCV of 14.7%. Luckily, we have the first world national program treating all our patients. It will be a good opportunity to discuss with the world experts in this field the results of their researches, and the real life results of different national protocols that are currently ongoing specially in the AsiaPacific region.

By reaching the date of the congress on September 2017, there will be more than one million Egyptian patients that have been cured from the virus using the currently available DAAs. The congress will provide an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries regarding the latest scientific and evidence-based research results and recommendations to follow-up the cured patients, to treat their damaged liver cells, to dissolve their fibrous bands, to detect and treat early any rising liver cancers. These elements are essential to pave a way for better treatment of HCV patients not only in the AsiaPacific region but among the world.

We planned to have 1 day of post-graduate educational program as well as 2 days for the core of the meeting. The core program is to provide an overview of different aspects of HCV with the State-of-the Art Lectures on hot-off-the-press issues. Free papers and poster presentations is always the soul of the conference to share research findings and there will be several awards available for application aimed to support young scientists to attend the conference and encourage scientific research. We thus enthusiastically invite all of you to submit abstract and join us in this conference.

In addition to the scientific program, an interesting social program for the doctors and their companions have been well prepared. Visiting the historical parts of old Cairo, the Coptics and the Islamic heritage as well as the pyramids, the sphinx and the old Egyptian museum will be memorial time. Luckily enough by September 2017, the outstanding new-Egyptian cultural museum will have its doors opened to show the largest collections of the era of Pharos. For those who have been prepared to have available time, it will be an outstanding chance having one of two options. Either to visit the two beauty cities in the upper Egypt, Luxur and Aswan to see the Temples, or to travel to one of the resorts or diving places in the north cost or the red sea (Hurgada and Sharm ElSheikh) that have been recognised as one of the highly ranked places for leisure.

We are waiting meeting you in Cairo, Egypt on September 6-8, 2017

Best of our Greetings


Prof. GAMAL SHIHA

President of the Congress


Prof. ALAAELDIN IBRAHIM

Vice-President of the Congress


APASL STC on HCV Treatment - The Real Life Results in Egypt

Date: September 6-8, 2017
City: Cairo, Egypt
President: Dr. GAMAL SHIHA
Website: To be announced


Future APASL Conferences


APASL STC on HCV and coinfection in Mongolia

Date: To be announced.
City: Ulaanbaatar, Mongolia
President: Dr. Oidov Baatarkhuu


APASL 2018 Annual Meeting in India

Date: March 15-18, 2018
City: New Delhi, India
President: Dr. Barjesh C. Sharma


APASL 2019 Annual Meeting in Philippines

Date: To be announced.
City: Manila, Philippines
President: Dr. Diana A. Payawal


APASL Guidelines

Now the APASL Guidelines have been published in Hepatology International as follows!!!

APASL Guidelines for HBV (Hepatol Int (2016) 10:1–98)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl-hbv-guideline-2016.pdf

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int DOI 10.1007/s12072-016-9717-6)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl-hcv-guideline-treatment-2016.pdf

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int DOI 10.1007/s12072-016-9736-3)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl-hcv-guideline-prevention-epidemiology-labotesting-2016.pdf

APASL Guidelines for HCC -”Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma” (Hepatol Int 2010; 4: 439-474)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guidelines-for-HCC-Management-2010.pdf

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guidelines-for-Acute-on-chronic-Liver-Failure-2014.pdf

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-Fibrosis.pdf

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-IPH.pdf

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-Variceal-Bleeding.pdf



APASL Fellowship 2017

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2017 fellowship.

An application form can be downloaded by clicking here: http://www.apasl.info/applicationform-fellowship.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.